Published in Cardiovasc Res on September 01, 1973
Prolactin alters blood pressure by modulating the activity of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (2016) 1.38
Effects of methyldopa on prolactin and growth hormone. Br Med J (1976) 1.11
The effect of chronic propranolol treatment on overnight plasma levels of anterior pituitary and related hormones. Br J Clin Pharmacol (1981) 1.04
Plasma prolactin level and risk of incident hypertension in postmenopausal women. J Hypertens (2010) 0.87
The effect of chronic oxprenolol therapy on blood prolactin, growth hormone, renin and aldosterone levels. Br J Clin Pharmacol (1979) 0.84
The effects of propranolol and acebutolol on the overnight plasma levels of anterior pituitary and related hormones. Br J Clin Pharmacol (1981) 0.82
Relationship between serum prolactin concentration, vascular angiotensin sensitivity and arterial blood pressure during third trimester pregnancy. Arch Gynecol Obstet (1988) 0.81
The effects of bromocriptine in methyldopa treated hypertension. Br J Clin Pharmacol (1980) 0.81
Prolactin in hypertensive pregnancy. Br Med J (1975) 0.79
Letter: Prolactin and pre-eclampsia. Br Med J (1975) 0.75
Referees and research administrators: barriers to scientific research? Br Med J (1974) 3.52
Something rotten at the core of science? Trends Pharmacol Sci (2001) 2.15
Actions of prolactin on human renal function. Lancet (1971) 2.06
Evening primrose oil in atopic eczema. Lancet (1990) 2.01
Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst (1986) 1.87
Schizophrenia as a prostaglandin deficiency disease. Lancet (1977) 1.64
Evening primrose oil and atopic eczema. Lancet (1995) 1.51
Inhibition of neutrophil respiratory burst and cytokine priming by gamma-linolenic acid. Br J Surg (1996) 1.39
Ideas in biomedical science: reasons for the foundataion of Medical Hypotheses. Med Hypotheses (1976) 1.39
Chloroquine, quinine, procaine, quinidine, tricyclic antidepressants, and methylxanthines as prostaglandin agonists and antagonists. Lancet (1976) 1.31
The form of sodium-calcium competition at the frog myoneural junction. J Gen Physiol (1968) 1.28
Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst (1988) 1.27
Effects of prolactin on the responses of rat aortic and arteriolar smooth-muscle preparations to noradrenaline and angiotensin. Lancet (1973) 1.25
Treatment of atopic eczema with evening primrose oil. Lancet (1981) 1.24
Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukot Med (1985) 1.20
The lateral cervical nucleus of the cat; an electrophysiological study. Q J Exp Physiol Cogn Med Sci (1966) 1.20
Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol (1989) 1.17
Essential fatty acids in the plasma phospholipids of patients with atopic eczema. Br J Dermatol (1984) 1.16
Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor. Biochem Biophys Res Commun (1978) 1.14
Dietary fibre and blood pressure. Br Med J (1979) 1.12
The role of essential fatty acids and prostaglandins in the premenstrual syndrome. J Reprod Med (1983) 1.11
Calcium metabolism, osteoporosis and essential fatty acids: a review. Prog Lipid Res (1997) 1.10
The reversibility of cancer: the relevance of cyclic AMP, calcium, essential fatty acids and prostaglandin E1. Med Hypotheses (1980) 1.10
Letter: Prolactin, bromocriptine, and haemostasis. Br Med J (1975) 1.10
Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial. Neurology (2005) 1.09
Chloroquine, quinine, procaine, quinidine and clomipramine are prostaglandin agonists and antagonists. Prostaglandins (1976) 1.06
Fatty acid levels in the brains of schizophrenics and normal controls. Biol Psychiatry (1991) 1.04
Realism in drug discovery-could Cassandra be right? Nat Biotechnol (2001) 1.03
Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience (1999) 1.01
Prolactin as a regulator of fluid and electrolyte metabolism in mammals. Fed Proc (1980) 1.01
Schizophrenia: the role of abnormal essential fatty acid and prostaglandin metabolism. Med Hypotheses (1983) 1.00
Polyunsaturated fatty acids augment free radical generation in tumor cells in vitro. Biochem Biophys Res Commun (1987) 1.00
Indomethacin inhibits responses to all vasoconstrictors in the rat mesenteric vascular bed: restoration of responses by prostaglandin E2. Prostaglandins (1976) 0.99
Beyond conflict of interest. Non-financial conflicts of interest are more serious than financial conflicts. BMJ (1999) 0.99
A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophr Res (1994) 0.99
Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids. Biochem Biophys Res Commun (1998) 0.98
Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA). Cancer Res (1995) 0.98
Effects of a high fat diet and of intravenous infusions of cholesterol on arterial pressure in rabbits. Br J Exp Pathol (1972) 0.98
The paradox of antioxidants and cancer. Am J Clin Nutr (2001) 0.97
Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. Br J Cancer (1995) 0.97
Changes of vascular reactivity induced by low vasopressin concentrations: interactions with cortisol and lithium and possible involvement of prostaglandins. Endocrinology (1978) 0.96
The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats. Pharmacopsychiatry (2006) 0.94
Aspirin, indomethacin, catecholamine and prostaglandin interactions on rat arterioles and rabbit hearts. Nature (1974) 0.94
Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content. Int J Biochem Cell Biol (1998) 0.93
Methyl xanthine phosphodiesterase inhibitors behave as prostaglandin antagonists in a perfused rat mesenteric artery preparation. Prostaglandins (1977) 0.93
A theory of hypertension. Lancet (1966) 0.92
Induction of labour in sheep and in humans by single doses of corticosteroids. Br Med J (1973) 0.92
Essential fatty acids, prostaglandins, and alcoholism: an overview. Alcohol Clin Exp Res (1987) 0.92
Interactions between prostaglandins and calcium: the importance of bell-shaped dose-response curves. Prostaglandins (1977) 0.92
Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease. A population-based case-control study. Arterioscler Thromb (1994) 0.91
Interferon fever. Lancet (1977) 0.91
Effects of prostaglandins on baseline pressure and responses to noradrenaline in a perfused rat mesenteric artery preparation. PGE1 as an antagonist of PGE2. Prostaglandins (1977) 0.91
Saluretic action of aldosterone in the presence of increased salt intake and restoration of normal action by prolactin or by oxytocin. J Endocrinol (1972) 0.91
Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover. Int J Clin Pract (2001) 0.91
Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. Br J Cancer (1991) 0.90
Abnormalities of thymus growth in dystrophic mice. Nature (1976) 0.90
Milk, serum cholesterol, and the Maasai. A hypothesis. Atherosclerosis (1980) 0.90
Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjogren's syndrome. Med Hypotheses (1984) 0.90
Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Crit Rev Oncol Hematol (1998) 0.89
Age-related changes in LTP and antioxidant defenses are reversed by an alpha-lipoic acid-enriched diet. Neurobiol Aging (2000) 0.89
Chloroquine enhances Epstein-Barr virus expression. Nature (1978) 0.89
Increased release of prostaglandins from the mesenteric vascular bed of diabetic animals: the effects of glucose and insulin. Prostaglandins Leukot Med (1986) 0.89
The effect of intravenous aldosterone on arterial pressure in the rabbit and its modification by variations in diet. J Endocrinol (1971) 0.88
Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy. Prostaglandins Leukot Med (1982) 0.88
Uptake and distribution of cis-unsaturated fatty acids and their effect on free radical generation in normal and tumor cells in vitro. Free Radic Biol Med (1987) 0.88
The regulation of prostaglandin biosynthesis by the manipulation of essential fatty acid metabolism. Rev Pure Appl Pharmacol Sci (1987) 0.88
The effects of progesterone on the responses of the cardiovascular system to intravenous infusions of aldosterone. J Obstet Gynaecol Br Commonw (1970) 0.88
Modification of liver fatty acid metabolism in mice by n-3 and n-6 delta 6-desaturase substrates and products. Biochim Biophys Acta (1991) 0.88
Letter: Prolactin and myocardial infarction. Lancet (1973) 0.87
Sodium and water metabolism under the influence of prolactin, aldosterone, and antidiuretic hormone. J Physiol (1978) 0.87
Prostaglandin E1 modifies nerve conduction and interferes with local anaesthetic action. Prostaglandins (1977) 0.87
Plasma phospholipid essential fatty acids and prostaglandins in alcoholic, habitually violent, and impulsive offenders. Biol Psychiatry (1987) 0.87
Adenosine as a natural prostaglandin antagonist in vascular smooth muscle. Prostaglandins (1977) 0.87
Chlorpropamide/alcohol flushing and prostaglandins. Lancet (1980) 0.86